NCT07504965 · RECRUITING
Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
This study is testing whether pharmacies can serve as early detection hubs for mild cognitive impairment. Trained pharmacy staff use a digital memory screening tool to flag people who may be experiencing cognitive changes, then refer them to specialists or support services. It is an observational cohort study, not a drug trial, so there is no experimental treatment involved. Details on phase are not specified, as this is a screening and care-pathway study rather than a traditional clinical trial.
Eligibility criteria
Inclusion Criteria 1. Age: Participants must be 60 years or older at the time of consent. 2. Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study. 3. Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes). 4. Consent: Ability to provide informed consent voluntarily. Exclusion Criteria 1. Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires. 2. Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology. 3. Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process. These criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-01